SCHEMBL30962582

SCHEMBL30962582

COc1nc(Cl)ncc1C(=O)Nc1c(Cl)cccc1Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 2/20 0.41
▸ ATF1 P18846 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KEAP1 Q14145 1/20 0.39
▸ NFE2L2 Q16236 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ CCR4 P51679 1/20 0.38
▸ PDE4D Q08499 2/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962863 0.94 NFKB1 (0.42) ATF1NFKB1KMT2AMEN1MAPT
SCHEMBL30962730 0.92 POLB (0.46) CHRNA7ATF1NFKB1KMT2AMEN1
SCHEMBL30962872 0.89 NFKB1 (0.39) ATF1NFKB1KMT2AMEN1MAPT
SCHEMBL30962625 0.89 PDE4D (0.47) ATF1NFKB1HPGDTSHRSMN1; SMN2
SCHEMBL30962916 0.89 GAA (0.46) CHRNA7KMT2ATSHRPOLBALDH1A1
SCHEMBL30962909 0.89 GAA (0.46) CHRNA7KMT2ATSHRPOLBALDH1A1
SCHEMBL30962894 0.87 CHRNA7 (0.48) CHRNA7ATF1NFKB1KMT2AMEN1
SCHEMBL30962814 0.86 PIN1 (0.45) ATF1NFKB1RAB9APDE4DPDE4A
SCHEMBL30962627 0.85 PDE4A (0.43) CHRNA7ATF1NFKB1KMT2AMEN1
SCHEMBL30962583 0.84 NFKB1 (0.47) CHRNA7ATF1NFKB1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
Send feedback